The deadline for Plan Sponsors to submit considerable and illusive drug spend data required under the Consolidated Appropriations Act (“CAA”) is December 27, 2022. The CAA requires group health plans and health insurers to submit prescription... Read More
Articles | Plan Sponsor PBM Contract Services

The recent increase in proposed State Legislature across the U.S. in an effort to regulate Pharmacy Benefit Managers (“PBMs”) demonstrates rising scrutiny by the government into the abusive conduct of PBMs and the impact it has on American... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Plan Sponsor PBM Contract Services

In May 2022, Johnson & Johnson (“JNJ”) filed a lawsuit against Save On SP, LLC (“SaveOnSP”), essentially alleging that SaveOnSP illegally pilfered co-payment coupon and manufacturer assistance programs offered by JNJ to help patients... Read More
Articles | Manufacturers | Pharmaceutical Manufacturers | Plan Sponsor PBM Contract Services

On Friday, June 17, 2022, the House Committee on Education and Labor (the Committee) issued a letter (the Letter) requesting the Hon. Gene L. Dodaro, U.S. Comptroller General and head of the Government Accountability Office (GAO) to conduct a study... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Life Sciences | Pharmacy Law | Plan Sponsor PBM Contract Services

The New York State Department of Financial Services’ recently established Pharmacy Benefits Bureau (“Bureau”) has requested additional Public Comments regarding Pharmacy Benefit Managers (“PBMs”) in New York. The Bureau, as an... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Defending Pharmacies in PBM Audits | Life Sciences | News | Pharmacy Law | Plan Sponsor PBM Contract Services | Section 340B In-House and Contract Pharmacies

Last week, the Federal Trade Commission (“FTC”) fired a warning shot across the bow of PBMs, but Manufacturers and Plan Sponsors must also take note. On June 16, 2022, the FTC announced that it will “ramp up enforcement against any illegal... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Life Sciences | Pharmacy Law | Plan Sponsor PBM Contract Services

Far too many pharmacy benefit managers (PBMs) thrive on opacity in their business operations, but sometimes public litigation shines the light of day on secretive practices. In this article published by BenefitsPRO, Frier Levitt Co-Founding Partner... Read More
Articles | Defending Pharmacies in PBM Audits | Life Sciences | News | Plan Sponsor PBM Contract Services

Frier Levitt recently assisted a California-based independent pharmacy that faced an audit from a major pharmacy benefit manager (“PBM”) by successfully challenging the audit findings and reducing the audit discrepancies by $159,438.46.  During... Read More
Defending Pharmacies in PBM Audits | News | Pharmacy Law | Plan Sponsor PBM Contract Services | Recent Results

On February 23, 2022, Michigan Governor Gretchen Whitmer signed into law House Bills 4348, 4351, and 4352, each tailored to address Pharmacy Benefit Managers’ (PBMs) discriminatory treatment of 340B entities. The signing of these Bills comes less... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Defending Pharmacies in PBM Audits | Life Sciences | Maximum Allowable Cost Pricing & Appeals | Pharmacy Law | Plan Sponsor PBM Contract Services | Section 340B In-House and Contract Pharmacies